My post on ihub concerning Agua77 (Toadly whiplash) post

New Post Public Reply Private Reply Replies (1) Message Board
martymech
193
My post on ihub concerning Agua77 (Toadly whiplash) post trying to rustle up some cheap shares because he.. Well who really knows what motivates that lad. Here's the post:
=====================================

Re: martymech post# 60731

Saturday, April 29, 2023 1:11:33 PM
Post# of 60733
To make a claim that all reverse splits act the same way or even make a claim that 90 percent have followed this dark pattern of going down and then throwing EGOC into some nice neat little package of following suit even in the face of the facts and charts showing the opposite has been true with EGOC is.... well quite frankly it shows a real lack of understanding. Each case is different and to lump every stock into some stereotypical class is silly. Many stocks and more importantly their share holders have seen great benefits during and after a reverse split. I always get a kick out of how some create fear even in the face of a stock going up in price multiple times it's pre split price.. I am awe struck once again at the lack of real understanding concerning this particular RS. Those negative claims look like gas lighting 101 to me. especially when you look at the facts and not some one size fits all False and Misleading scenario !

The fact of the matter is that EGOC and it's shareholders (those here that actually own shares of EGOC) stand to benefit greatly from a reverse split IF the conditions for such a reverse split are positive and goal oriented towards something like uplisting to a higher board . In our case the share structure now is awesome and the price per share has been for the most part steadily going up prior to, during and after the split process. EGOC stated they want to move to a higher bigger board.. check! Share structure is now highly inviting for New investors and old investors alike! Check. Acquisition of new company happened along with press release letting us know of more businesses being rolled into EGOC with projects already in place for said business ! Check! EGOC now enjoys Current filing status and no "expert market" threat ! Check. More filings and news expected ! Check. The list is a long one for sure and we all can see how EGOC's stock price has been trending up for a couple of weeks now. Gas lighting 101 doesn't seem to have worked too well in tanking the stock price of EGOC . One day of pause out of say 3 weeks is nothing in the big picture! We saw a healthy pause on Friday in order to let a couple of share holders off the bus while grabbing their shares. Their loss not mine. I think it's safe to say that the EGOC Roll out is in full throttle mode "finally" and it's a good thing!

Here is the last press release dated April 18. Good stuff. Now it's time to go golfing. Just my opinions.


https://www.prnewswire.com/news-releases/egoc...00170.html
Bullish
Bullish

Energy 1 Corporation (EGOC) Stock Research Links

EGOC Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinions and thoughts based on my research. Please do your own DD before buying or selling any stock. I am just as capable as the next guy in making good or bad investment choices! We win a few, we lose a few. That is the nature of the game!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 20

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading